Synaptogenix, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Synaptogenix, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
  • Synaptogenix, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.42K, a 99% decline year-over-year.
  • Synaptogenix, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $48K, a 98.2% decline year-over-year.
  • Synaptogenix, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.01M, a 43.2% decline from 2022.
  • Synaptogenix, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.78M, a 74% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $48K $3.42K -$331K -99% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $379K $14.4K -$630K -97.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.01M $15.1K -$1.7M -99.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.71M $15.1K +$4.45K +42% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.71M $334K +$323K +2797% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.39M $645K +$608K +1673% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.78M $1.72M +$1.57M +1067% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $206K $10.6K -$144K -93.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $349K $11.5K -$140K -92.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $489K $36.4K -$532K -93.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.02M $147K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 $154K -$234K -60.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $152K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $568K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $388K -$537K -58.1% Jul 1, 2020 Sep 30, 2020 10-Q 2020-12-23
Q3 2019 $925K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.